Bong Hyun Chung

USPTO Granted Patents = 26 (Patent Applications = 13)

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 15)

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 59(Granted Patents)

Location History:

Taejun, KR (1997)
Taejeon, KR (2007)
Taejeon-si, KR (2012 - 2014)
Daejeon, KR (1998 - 2018)
Seoul, KR (1990 - 2024)

Company Filing History:

16 out of 321

Korea Research Institute of Bioscience and Biotechnology

patents

4 out of 2,169

Korea Institute of Science and Technology

patents

2 out of 25

Dongkook Pharmaceutical Co., Ltd.

patents

4. 2 out of 5

Bionano Health Guard Research Center

patents

5. 2 out of 2

Haesung Bio Co., Ltd.

patents

6. 1 out of 2,619

Korea Advanced Institute of Science and Technology

Micobiomed. Co., Ltd.

patents

9. 1 out of 1

Nanobiotech Co., Ltd.

patent

where one patent can have more than one assignee

Years Active: 1990-2024

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11982619 - Method for detecting biomaterial using linear upconversion fluorescent property (2024-05-14),

2. 10761025 - Method for detecting biomaterial using linear upconversion fluorescent property (2020-09-01),

3. 10663459 - Composition for detecting microbial contamination comprising preparation for detecting nucleases, and use thereof (2020-05-26),

4. 10634674 - Probe for detecting bacteria using peptidoglycan-binding protein, and use thereof (2020-04-28),

5. 9914757 - Methionyl tRNA synthetase for biosynthesis of photomethionine-labeled protein and method for preparing photoactive protein G variant using same (2018-03-13),

6. 9617543 - Sugar chain-containing polymer, and sugar chain-containing polymer complex (2017-04-11),

7. 9487596 - Compound isolated from quamoclit, and composition for preventing or treating diabetes containing the compound as an active ingredient (2016-11-08),

8. 9326940 - Asymmetric liposomes for the highly efficient encapsulation of nucleic acids and hydrophilic anionic compounds, and method for preparing same (2016-05-03),

9. 9079837 - Water-soluble fluorescent fullerene derivative, and preparation method thereof (2015-07-14),

10. 9022997 - Microneedle unit capable of controlling fluid delivery (2015-05-05),

11. 8785598 - Coenzyme Q10 nanoparticles, preparation method thereof and composition containing said nanoparticles (2014-07-22),

12. 8758822 - Method for manufacturing uniform size polymeric nanoparticles containing poorly soluble drugs (2014-06-24),

13. 8753606 - Multimodal imaging method using nano-emulsion comprising optical nano-particles and perfluorocarbons (2014-06-17),

14. 8734762 - Perfluorocarbon nano-emulsion containing quantum dot nanoparticles and method for preparing the same (2014-05-27),

15. 8715738 - Fullerene-silica nanoparticles with improved fluorescence, preparation method thereof and use thereof (2014-05-06),

Bong Hyun Chung: Innovating Biomaterial Detection

Introduction

Bong Hyun Chung, based in Daejeon, South Korea, is a prolific inventor with an impressive portfolio of 26 patents. His contributions to the field of biomaterial detection have set benchmarks in innovative methodologies and applications, showcasing his commitment to advancing scientific understanding.

Latest Patents

One of Bong Hyun Chung's latest inventions is a method for detecting biomaterial using a linear upconversion fluorescent property. This advanced method involves several steps: preparing a fluorophore with linear upconversion fluorescent properties, reacting the fluorophore with a biomaterial to produce a reaction complex, and exciting the complex with a light source that has a longer wavelength than the maximum light-emitting wavelength of the fluorophore. The final step includes detecting and measuring the emitted light signal, which has a shorter wavelength than that of the excited light. Additionally, the method encompasses a system and kit designed for biomaterial detection using the aforementioned dye properties.

Career Highlights

Throughout his career, Bong Hyun Chung has been associated with prominent research institutions, including the Korea Research Institute of Bioscience and Biotechnology and the Korea Institute of Science and Technology. His work has significantly contributed to advancements in life sciences and bioengineering, echoing his dedication to research and innovation.

Collaborations

Bong Hyun Chung has collaborated with notable colleagues such as Yong Taik Lim and Jung Hyun Han, enhancing the potential for interdisciplinary approaches in their scientific explorations. Their joint efforts reflect a synergy that has furthered innovation in the field of biomaterials.

Conclusion

Bong Hyun Chung's contributions to the science of biomaterials, highlighted by his innovative patents, demonstrate a relentless pursuit of knowledge and excellence. His methodologies are not only groundbreaking but also indicative of the future directions in biomedical research and application. As the field continues to evolve, innovators like Bong Hyun Chung will undoubtedly play a pivotal role in shaping the landscape of scientific discovery.

This text is generated by artificial intelligence and may not be accurate.